- Home
- PEP vs NVS Comparison
PEP vs NVS Comparison
Compare PEP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEP
- NVS
- Stock Information
- Founded
- PEP 1898
- NVS 1895
- Country
- PEP United States
- NVS Switzerland
- Employees
- PEP N/A
- NVS N/A
- Industry
- PEP Beverages (Production/Distribution)
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- PEP Consumer Staples
- NVS Health Care
- Exchange
- PEP Nasdaq
- NVS Nasdaq
- Market Cap
- PEP 201.9B
- NVS 230.5B
- IPO Year
- PEP N/A
- NVS 1991
- Fundamental
- Price
- PEP $145.64
- NVS $110.41
- Analyst Decision
- PEP Buy
- NVS Hold
- Analyst Count
- PEP 16
- NVS 6
- Target Price
- PEP $170.14
- NVS $123.67
- AVG Volume (30 Days)
- PEP 7.4M
- NVS 2.6M
- Earning Date
- PEP 04-24-2025
- NVS 04-29-2025
- Dividend Yield
- PEP 3.72%
- NVS 2.97%
- EPS Growth
- PEP 5.95
- NVS N/A
- EPS
- PEP 6.95
- NVS 5.87
- Revenue
- PEP $91,854,000,000.00
- NVS $51,722,000,000.00
- Revenue This Year
- PEP $1.15
- NVS $4.36
- Revenue Next Year
- PEP $3.62
- NVS $1.93
- P/E Ratio
- PEP $20.94
- NVS $18.79
- Revenue Growth
- PEP 0.42
- NVS 10.85
- 52 Week Low
- PEP $141.51
- NVS $92.35
- 52 Week High
- PEP $183.41
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- PEP 40.32
- NVS 51.19
- Support Level
- PEP $144.75
- NVS $111.15
- Resistance Level
- PEP $151.67
- NVS $113.38
- Average True Range (ATR)
- PEP 2.76
- NVS 1.52
- MACD
- PEP -0.83
- NVS -0.35
- Stochastic Oscillator
- PEP 4.44
- NVS 29.88
About PEP PepsiCo Inc.
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US and overseas. International markets make up 40% of total sales and one third of operating profits.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.